The results revealed that tumours with higher TRIM21 or lower VDAC2 expression levels were infiltrated with fewer CD3+ CD8+ T cells and CD11c+ DCs, indicating weaker antitumour immunity (Fig. 7c, d and Supplementary Fig. 8a). Here, ITGAX is linked to neoplasm.